ArticleScientific reports2025
Active surveillance of multidrug-resistant organism colonization in a tertiary hospital in Northern Greece.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- [Advances in the diagnosis and treatment of patients with multidrug-resistant bacterial infections combined with severe liver disease].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026Review
- Tackling a global threat: a clinical scenario-based framework for preventing and managingFrontiers in cellular and infection microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multidrug-resistant organisms (MDROs) pose a growing threat in healthcare settings. Timely detection through active surveillance is essential for infection prevention and antimicrobial stewardship. This study investigated the prevalence and microbiological profile of MDRO colonization among hospitalized patients at AHEPA University Hospital in Thessaloniki, Greece. A prospective surveillance study was conducted from October 2024 to January 2025 across multiple hospital wards. Screening swabs from the rectum, groin, and nares were obtained upon admission or during hospitalization. Microbiological analysis targeted key MDROs, including Klebsiella pneumoniae, Pseudomonas aeruginosa, vancomycin-resistant enterococci (VRE), Candida auris, and methicillin-resistant Staphylococcus aureus (MRSA). Among 1206 patients screened, 308 (25.5%) tested positive for at least one MDRO. Rectal swabs yielded the highest detection rates, predominantly identifying K. pneumoniae and VRE. Candida auris was most frequently isolated from groin swabs, while nasal swabs rarely detected MDROs. Internal medicine wards exhibited the highest colonization burden. Contact tracing and prolonged hospitalization were the most common indications for screening. This study highlights the high prevalence and diverse spectrum of MDRO colonization in a Greek tertiary hospital. Targeted screening- especially of rectal and groin sites-facilitates early detection and effective infection control. Continued surveillance is essential to mitigate MDRO transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.